| Literature DB >> 29599494 |
Huan Yu1,2, Zi-Qi Li1,2, Lei He1,2, Yi-Yi Ou-Yang1,2, Ni Li1,2, Guo-Hua Huang3,4.
Abstract
Heliothis virescens ascovirus 3 h (HvAV-3h), a dsDNA insect virus, belonging to the family Ascoviridae, can infect caterpillars of several Noctuidae species by ovipositing parasitoid wasps. In order to provide a comprehensive overview of the interactive responses of host larvae after infection by the ascovirus, a transcriptome analysis of Spodoptera exigua to HvAV-3h was conducted from 6 to 168 hours post infection (hpi). Approximately 101.64 Gb of RNA sequencing (RNA-seq) data obtained from infected and uninfected S. exigua larvae were used to perform a de novo transcriptome assembly, which generated approximately 62,258 S. exigua unigenes. Using differential gene expression analysis, it was determined that the majority of host transcripts were down-regulated beginning at 6 hpi and continuing throughout the infection period, although there was an increase in up-regulated unigene number during the 12 to 72 hpi stage. It is noteworthy that the most abundantly enriched pathways in KEGG annotation were Metabolism terms, indicating that the host larval metabolic mechanisms were highly influenced post HvAV-3h infection. In addition, the host cuticle protein encoding unigenes were highly down-regulated in most of the situations, suggesting that the host larval cuticle synthesis were inhibited by the viral infection.Entities:
Mesh:
Year: 2018 PMID: 29599494 PMCID: PMC5876357 DOI: 10.1038/s41598-018-23715-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1General analyses of host larval expressed genes responding to HvAV-3h infection. (A) The volcano plots of up-regulated unigenes (Red dots), down-regulated unigenes (Blue dots), and non-differentially expressed unigenes (Black dots) illustrating comparisons between different time points versus CK (the horizontal axis, A1 to A4) and comparisons between adjacent time points (the vertical axis, A1, A5 to A7). Cluster analyses of DEGs from different HvAV-3h infected time points compared with CK. In the intersection cluster analysis of DEGs (B), two major sub-groups were included (B1-B2), the DEGs from 12 h vs CK showed a expression pattern similar to 168 h vs CK (IS1), the remaining two compared groups were clustered into an IS2 group. In the union DEGs cluster analysis (C), two major sub-groups were included (C1-C2), the DEGs from 6 h vs CK showed a expression pattern similar to 12 h vs CK (US1), the remaining two compared group were clustered into a US2 sub-group.
Numbers of up- and down-regulated unigenes at various times post infection compared to CK.
| Unigene category | Log2Fold change* | No. of genes | |||
|---|---|---|---|---|---|
| 6 h | 12 h | 72 h | 168 h | ||
| Up-regulated | ≥10 | 14 | 16 | 42 | 39 |
| 5–10 | 181 | 139 | 342 | 303 | |
| 0–5 | 51 | 66 | 101 | 102 | |
| Down-regulated | 0–5 | 52 | 97 | 110 | 128 |
| 5–10 | 63 | 364 | 221 | 529 | |
| ≥10 | 0 | 14 | 8 | 69 | |
| Total regulated | 360 | 696 | 824 | 1170 | |
*Probability P value > 0.8.
Extremely expressed unigenes in DEGs cluster analyses of different time point vs CK comparisons.
| Unigene | Average FPKM values | Annotation | |||
|---|---|---|---|---|---|
| 6 h vs CK | 12 h vs CK | 72 h vs CK | 168 h vs CK | ||
| Three excption unigenes in sub-group B1, Fig. | |||||
| CL42.Contig6_All | −5.03 | −3.93 | 4.4 | −4.01 | REPAT41 [ |
| CL3006.Contig1_All | −3.42 | −5.21 | 3.51 | −5.46 | Cuticular proteinprecursor [ |
| Unigene18832_All | −3.23 | −6.59 | 2.67 | −6.63 | Cuticular protein precursor [ |
| Three always highly simulated unigenes in sub-group B2, Fig. | |||||
| CL3324.Contig3_All | 12.03 | 11.6 | 12.51 | 12.49 | KRAB-A domain-containing [ |
| CL3324.Contig1_All | 12.75 | 12.3 | 13.27 | 13.16 | KRAB-A domain-containing [ |
| Unigene12856_All | 13 | 12.76 | 13.66 | 12.23 | Uncharacterized protein [ |
| Thirteen unigenes with a depressed expression level below 7.37 log2Fold values in sub-group C1, Fig. | |||||
| CL3373.Contig2_All | −7.43 | −2.09 | −7.43 | −7.43 | NA |
| Unigene26374_All | −7.78 | −1.29 | −7.78 | −7.78 | NA |
| CL1931.Contig5_All | −8.15 | −8.15 | −8.15 | −8.15 | Calpain-B [ |
| Unigene3740_All | −8.28 | −8.28 | −8.28 | −8.28 | Lipophorin receptor protein [ |
| Unigene33959_All | −7.51 | −7.51 | −7.51 | −7.51 | NA |
| Unigene27464_All | −7.43 | −7.43 | −7.43 | −7.43 | NA |
| Unigene26275_All | −7.37 | −7.37 | −7.37 | −7.37 | NA |
| Unigene26141_All | −7.4 | −7.4 | −7.4 | −7.4 | NA |
| Unigene26186_All | −7.39 | −7.39 | −7.39 | −7.39 | NA |
| Unigene25589_All | −7.88 | −7.88 | −7.88 | −7.88 | Uroplakin-1a [ |
| Unigene21459_All | −7.74 | −7.74 | −7.74 | −7.74 | NA |
| Unigene25368_All | −7.63 | −7.63 | −7.63 | −7.63 | NA |
| Unigene25614_All | −7.63 | −7.63 | −7.63 | −7.63 | NA |
| Twelve highly stimulated unigenes in sub-group C2, Fig. | |||||
| CL3324.Contig3_All | 12.03 | 11.6 | 12.51 | 12.49 | KRAB-A domain-containing protein [ |
| CL3324.Contig1_All | 12.75 | 12.3 | 13.27 | 13.16 | KRAB-A domain-containing protein [ |
| Unigene12856_All | 13 | 12.76 | 13.66 | 12.23 | Uncharacterized protein [ |
| CL1205.Contig2_All | 10.83 | 10.12 | 11.24 | 11.08 | NA |
| CL2935.Contig2_All | 10.88 | 10.4 | 11.41 | 11.15 | NA |
| CL2513.Contig5_All | 10.97 | 10.35 | 11.46 | 11.36 | NA |
| CL2935.Contig7_All | 10.94 | 10.39 | 11.38 | 11.36 | NA |
| CL1068.Contig2_All | 10.42 | 11.47 | 11.92 | 11.54 | Cytochrome [ |
| CL847.Contig1_All | 10.39 | 11.44 | 10.89 | 10.86 | NIPSNAP protein [ |
| CL1230.Contig1_All | 9.68 | 9.61 | 11.8 | 12.39 | Probable pterin-4-alpha-carbinolamine dehydratase [ |
| CL4264.Contig3_All | 9.21 | 10.24 | 11.38 | 11.07 | Phosphoribosylformylglycinamidine synthase [ |
| CL58.Contig3_All | 10.13 | 9.6 | 10.73 | 10.64 | KRAB-A domain-containing protein [ |
Figure 2Venn diagrams and KEGG annotation of host larval responding genes in different HvAV-3h infection stages. (A) Venn diagram of DEGs from 6 h vs CK, 12 h vs CK and 12 h vs 6 h representing the ascovirus early infectious stage, 81 hypothetical host initial responding genes are illustrated. (B) Venn diagram of DEGs from 12 h vs 6 h, 72 h vs 6 h, and 72 h vs 12 h representing the ascovirus mass propagation stage, 372 hypothetical host strong defense responding genes are illustrated. (C) Venn diagram of DEGs from 72 h vs 12 h, 168 h vs 12 h, and 168 h vs 72 h representing the ascovirus late infectious stage, 107 hypothetical host late responded genes are illustrated. (D) The Diseases in KEGG annotation of host larval DEGs from different comparable groups. (E) The Metabolism in KEGG annotation of host larval DEGs from different comparable groups.
Figure 3GO enrichment analyses of DEGs among different infected time points compared to CK. GO enrichment analyses of differentially expressed S. exigua transcripts were first separated into down-regulated unigenes (left portions of y-axis) and up-regulated unigenes (right portions of y-axis), and then illustrated in 6 h vs CK (A), 12 h vs CK (B), 72 h vs CK(C), and 168 h vs CK (D) comparison groups. Red columns represents molecular function, blue columns represents cellular component, and green columns represents biological process.
Figure 4KEGG analysis of S. exigua differentially expressed unigenes from different comparable groups. The DEG numbers and the percentage of each sub-level are labeled on each of the parts.
Most abundant DEGs enriched cellular processes pathways in KEGG.
| Comparison | Pathway | DEG Number | P value | Pathway ID | Sub-level | Unigenes |
|---|---|---|---|---|---|---|
| 6 h vs CK | Oocyte meiosis | 3 | 0.29 | ko04114 | Cell growth and death | CL3324.Contig1_All, CL3324.Contig3_All, Unigene19404_All |
| Apoptosis | 2 | 0.47 | ko04210 | Cell growth and death | CL375.Contig6_All, CL6434.Contig13_All | |
| p53 signaling pathway | 1 | 0.66 | ko04115 | Cell growth and death | CL2926.Contig4_All | |
| Cell cycle | 1 | 0.86 | ko04110 | Cell growth and death | Unigene18832_All | |
| Regulation of actin cytoskeleton | 4 | 0.97 | ko04810 | Cell motility | Unigene14456_All, Unigene6183_All, CL6081.Contig3_All, CL1053.Contig1_All | |
| 12 h vs CK | p53 signaling pathway | 4 | 0.27 | ko04115 | Cell growth and death | CL46.Contig1_All, CL46.Contig4_All, CL46.Contig3_All, CL46.Contig12_All |
| Oocyte meiosis | 5 | 0.50 | ko04114 | Cell growth and death | CL3324.Contig1_All, CL3324.Contig3_All, Unigene19404_All, Unigene10341_All, CL2851.Contig3_All | |
| Apoptosis | 3 | 0.74 | ko04210 | Cell growth and death | Unigene4757_All, CL46.Contig6_All, Unigene8172_All | |
| Cell cycle | 3 | 0.86 | ko04110 | Cell growth and death | Unigene18832_All, Unigene24283_All, Unigene10341_All | |
| Regulation of actin cytoskeleton | 23 | 0.35 | ko04810 | Cell motility | CL2386.Contig2_All, Unigene15718_All, Unigene7475_All, Unigene6183_All, CL6091.Contig28_All, CL774.Contig3_All, Unigene10070_All, CL4153.Contig2_All, CL2386.Contig1_All, CL4277.Contig4_All, CL6091.Contig17_All, Unigene881_All, Unigene21742_All, Unigene7424_All, Unigene4361_All, Unigene16131_All, Unigene15581_All, Unigene13774_All, CL1853.Contig1_All, Unigene10341_All, Unigene17975_All, Unigene2176_All, Unigene15493_All | |
| 72 h vs CK | Regulation of actin cytoskeleton | 27 | 0.26 | ko04810 | Cell motility | CL4779.Contig1_All, CL304.Contig1_All, CL1053.Contig3_All, Unigene15718_All, Unigene6183_All, CL6091.Contig28_All, Unigene11423_All, Unigene837_All, CL6081.Contig3_All, CL1007.Contig9_All, CL774.Contig3_All, CL6163.Contig1_All, CL1937.Contig1_All, Unigene15208_All, Unigene21742_All, CL673.Contig2_All, Unigene5697_All, Unigene15581_All, Unigene836_All, CL1053.Contig1_All, Unigene1017_All, CL2101.Contig2_All, CL5337.Contig2_All, Unigene11370_All, Unigene2176_All, CL1823.Contig3_All, CL6091.Contig9_All |
| Cell cycle | 5 | 0.63 | ko04110 | Cell growth and death | CL639.Contig3_All, CL2725.Contig1_All, Unigene4970_All, Unigene18832_All, Unigene24283_All | |
| Oocyte meiosis | 4 | 0.77 | ko04114 | Cell growth and death | CL3324.Contig1_All, CL1937.Contig1_All, CL3324.Contig3_All, Unigene19404_All | |
| p53 signaling pathway | 2 | 0.80 | ko04115 | Cell growth and death | Unigene19495_All, CL2926.Contig4_All | |
| Apoptosis | 2 | 0.93 | ko04210 | Cell growth and death | CL6434.Contig8_All, CL512.Contig6_All | |
| 168 h vs CK | p53 signaling pathway | 8 | 0.085 | ko04115 | Cell growth and death | CL292.Contig9_All, CL46.Contig1_All, CL46.Contig4_All, CL46.Contig3_All, CL46.Contig12_All, Unigene19495_All, CL2926.Contig4_All, CL3077.Contig3_All |
| Oocyte meiosis | 5 | 0.90 | ko04114 | Cell growth and death | CL3324.Contig1_All, CL3324.Contig3_All, Unigene19404_All, Unigene10341_All, CL2851.Contig3_All | |
| Cell cycle | 5 | 0.91 | ko04110 | Cell growth and death | CL639.Contig3_All, CL2725.Contig1_All, Unigene18832_All, Unigene24283_All, Unigene10341_All | |
| Apoptosis | 3 | 0.96 | ko04210 | Cell growth and death | Unigene4757_All, CL46.Contig6_All, Unigene8172_All | |
| Regulation of actin cytoskeleton | 50 | 0.01 | ko04810 | Cell motility | CL4779.Contig1_All, CL3655.Contig1_All, CL2386.Contig2_All, Unigene17949_All, Unigene15718_All, CL1569.Contig5_All, Unigene7475_All, Unigene6183_All, CL6091.Contig28_All, Unigene11423_All, CL3212.Contig2_All, Unigene25270_All, Unigene837_All, CL3212.Contig1_All, CL1063.Contig1_All, CL774.Contig3_All, CL6163.Contig1_All, Unigene10070_All, Unigene2661_All, CL4153.Contig2_All, CL2386.Contig1_All, Unigene11289_All, CL1187.Contig2_All, Unigene881_All, Unigene872_All, Unigene19351_All, Unigene15208_All, Unigene21742_All, Unigene7424_All, Unigene4361_All, Unigene17223_All, CL5420.Contig3_All, Unigene16131_All, CL6091.Contig2_All, Unigene15581_All, CL5420.Contig2_All, Unigene836_All, Unigene1902_All, CL3685.Contig1_All, Unigene5296_All, Unigene5872_All, Unigene13774_All, Unigene11370_All, Unigene17826_All, CL1853.Contig1_All, Unigene10341_All, CL3502.Contig2_All, CL4812.Contig3_All, CL3212.Contig3_All, CL6091.Contig9_All |
Immunity pathways in different comparisons.
| Comparisons | Pathway | DEG Number | P Value | Pathway ID | Sub-level 1 | Sub-level 2 | Unigenes |
|---|---|---|---|---|---|---|---|
| 6 h vs CK | Insulin secretion | 5 | 0.02 | ko04911 | Organismal Systems | Endocrine system | CL3324.Contig1_All, CL3324.Contig3_All, Unigene705_All, Unigene19404_All, CL347.Contig1_All |
| Insulin signaling pathway | 2 | 0.91 | ko04910 | Organismal Systems | Endocrine system | CL1681.Contig2_All, CL3472.Contig2_All | |
| NF-kappa B signaling pathway | 5 | 0.013 | ko04064 | Environmental Information Processing | Signal transduction | CL375.Contig6_All, CL3324.Contig1_All, Unigene8993_All, CL3324.Contig3_All, CL58.Contig3_All | |
| NOD-like receptor signaling pathway | 1 | 0.63 | ko04621 | Organismal Systems | Immune system | CL375.Contig6_All | |
| 12 h vs CK | Insulin secretion | 5 | 0.33 | ko04911 | Organismal Systems | Endocrine system | CL3324.Contig1_All, CL3324.Contig3_All, Unigene705_All, Unigene19404_All, Unigene19354_All |
| Insulin signaling pathway | 8 | 0.76 | ko04910 | Organismal Systems | Endocrine system | CL1681.Contig2_All, Unigene4757_All, Unigene10070_All, CL46.Contig6_All, Unigene8172_All, CL1853.Contig1_All, Unigene10341_All, CL2851.Contig3_All | |
| Insulin resistance | 4 | 0.87 | ko04931 | Human Diseases | Endocrine and metabolic diseases | Unigene4757_All, CL46.Contig6_All, Unigene8172_All, CL1853.Contig1_All | |
| NF-kappa B signaling pathway | 5 | 0.25 | ko04064 | Environmental Information Processing | Signal transduction | CL3324.Contig1_All, Unigene8993_All, CL3324.Contig3_All, Unigene11306_All, CL58.Contig3_All | |
| Jak-STAT signaling pathway | 6 | 0.10 | ko04630 | Environmental Information Processing | Signal transduction | Unigene4757_All, Unigene10070_All, CL46.Contig6_All, Unigene8172_All, Unigene24283_All, Unigene10341_All | |
| 72 h vs CK | Insulin secretion | 5 | 0.43 | ko04911 | Organismal Systems | Endocrine system | CL3324.Contig1_All, CL3324.Contig3_All, Unigene705_All, Unigene19404_All, Unigene11630_All |
| Insulin resistance | 2 | 0.99 | ko04931 | Human Diseases | Endocrine and metabolic diseases | CL1681.Contig2_All, CL463.Contig1_All, CL1937.Contig1_All | |
| Insulin signaling pathway | 3 | 1.00 | ko04910 | Organismal Systems | Endocrine system | CL1681.Contig2_All, CL463.Contig1_All, CL1937.Contig1_All | |
| NF-kappa B signaling pathway | 6 | 0.18 | ko04064 | Environmental Information Processing | Signal transduction | CL6163.Contig1_All, CL3324.Contig1_All, Unigene8993_All, CL3324.Contig3_All, Unigene11306_All, CL58.Contig3_All | |
| Jak-STAT signaling pathway | 3 | 0.69 | ko04630 | Environmental Information Processing | CL639.Contig3_All, Unigene4970_All, Unigene24283_All | ||
| 168 h vs CK | Insulin secretion | 6 | 0.63 | ko04911 | Organismal Systems | Endocrine system | CL3324.Contig1_All, Unigene19278_All, CL3324.Contig3_All, Unigene705_All, Unigene19404_All, Unigene19354_All |
| Insulin resistance | 6 | 0.95 | ko04931 | Human Diseases | Endocrine and metabolic diseases | Unigene4757_All, CL1842.Contig6_All, CL46.Contig6_All, Unigene8172_All, CL1197.Contig3_All, CL1853.Contig1_All | |
| Insulin signaling pathway | 10 | 0.97 | ko04910 | Organismal Systems | Endocrine system | CL1681.Contig2_All, CL292.Contig9_All, Unigene4757_All, Unigene15555_All, Unigene10070_All, CL46.Contig6_All, Unigene8172_All, CL1853.Contig1_All, Unigene10341_All, CL2851.Contig3_All | |
| NF-kappa B signaling pathway | 6 | 0.51 | ko04064 | Environmental Information Processing | Signal transduction | CL6163.Contig1_All, CL3324.Contig1_All, Unigene8993_All, CL3324.Contig3_All, CL3534.Contig1_All, CL58.Contig3_All | |
| Jak-STAT signaling pathway | 7 | 0.29 | ko04630 | Environmental Information Processing | Signal transduction | Unigene4757_All, CL639.Contig3_All, Unigene10070_All, CL46.Contig6_All, Unigene8172_All, Unigene24283_All, Unigene10341_All |